Dr. Markus Schuler has been the Chief Physician of the Department of Oncology since September 2017 and is a specialist in internal medicine, hematology and internistic oncology, gastroenterology and palliative care within the Helios Emil von Behring Hospital in Berlin Zehlendorf. Previously, Dr. Schuler was the Chief Resident of Medical Clinic and Polyclinic I at the Carl Gustav Carus University Hospital at the Technical University of Dresden and the Section Head of Oncology in the Department of Internal Medicine II at the HELIOS Emil von Behring Hospital. Above all, the recently established Department of Oncology in the southwest of the capital provides those patients with an already advanced cancer condition with more than purely medical care. Together with oncology and hematology, palliative care constitutes a major focus of the therapeutic activity. In combination with, for example, high blood pressure, respiratory problems or chronic pain, particular demands are made of older patients. The optimal treatment can be achieved in all clinical phases by the overlapping clinical departments. Together with his team of colleagues, Chief Physician Dr. Schuler, who has specialized in geriatric oncology, provides sensitive, individual and qualified treatments and support. Here, close collaboration with the Departments of Nutrition Counseling, Physical Therapy, Psychooncology, Social Service, the Nursing and Hospice Service, the Chaplaincy Department and the internistic departments is highly prized. At the same time, the results of the weekly tumor conferences are also integrated into the therapeutic plan for the patient and are also discussed personally with the patients. Finally, only by taking the patient and his wishes into consideration can his quality of life be maintained to the greatest extent possible. For this reason, Dr. Schuler has ethics advice in his department. That means that all those involved in the treatment (all physicians, nursing staff and physical therapists) give their view as to how the treatment of the patient should proceed. Different professional groups invariably have a different perception of the patient's situation, and so different perspectives can also highlight different important aspects of the treatment. Dr. Schuler has high aspirations as to what affects the wellbeing of his patients. Thus, adapted nutrition cannot, in fact, work a miracle in cancer but the patient’s general condition can be improved and malnutrition can be counteracted. Hence, however, there is a good basis for the optimal therapeutic course of the treatment. Ultimately, this concerns reclaiming a small measure of normal everyday life for the patient.